About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Amhr2
anti-Mullerian hormone type 2 receptor
MGI:105062
127 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Amhtm1Bhr/Amh+
Amhr2tm1Bhr/Amhr2tm1Bhr
involves: 129S7/SvEvBrd * C57BL/6
increased testis tumor incidence J:36027
male pseudohermaphroditism J:36027
secondary sex reversal J:36027
Amhtm1Bhr/Amhtm1Bhr
Amhr2tm1Bhr/Amhr2tm1Bhr
Not Specified
male infertility J:36027
male pseudohermaphroditism J:36027
normal reproductive system phenotype J:36027
secondary sex reversal J:36027
Amhr2tm1Bhr/Amhr2tm1Bhr
Inhatm1Bay/Inha+
involves: 129S7/SvEvBrd * C57BL/6
increased testis tumor incidence J:36027
male pseudohermaphroditism J:36027
secondary sex reversal J:36027
Amhr2tm1Bhr/Amhr2tm1Bhr
Inhatm1Bay/Inhatm1Bay
involves: 129S7/SvEvBrd
dilated uterus J:36027
increased granulosa cell tumor incidence J:36027
increased Leydig cell tumor incidence J:36027
increased testis tumor incidence J:36027
increased tumor incidence J:36027
male pseudohermaphroditism J:36027
secondary sex reversal J:36027
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S/SvEv * C57BL/6
early reproductive senescence J:128934
hemoperitoneum J:128934
increased ovarian carcinoma incidence J:128934
increased ovary tumor incidence J:128934
increased testis tumor incidence J:128934
male infertility J:128934
Amhr2tm3(cre)Bhr/Amhr2+
KitW-v/KitW-v
Trp53tm1Brn/Trp53tm1Brn
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J * FVB/N
increased granulosa cell tumor incidence J:236161
increased ovary adenoma incidence J:236161
increased ovary tumor incidence J:236161
Amhr2tm3(cre)Bhr/Amhr2+
Nr5a1tm1Klp/Nr5a1tm2Klp
involves: 129P2/OlaHsd * 129S7/SvEvBrd
abnormal ovulation J:91352
abnormal seminiferous tubule morphology J:91352
abnormal testis cord formation J:91352
abnormal testis development J:91352
absent corpus luteum J:91352
absent sexual maturation J:91352
arrest of spermatogenesis J:91352
cryptorchism J:91352
decreased circulating testosterone level J:91352
decreased mature ovarian follicle number J:91352
female infertility J:91352
internal male genitalia hypoplasia J:91352
male infertility J:91352
ovarian follicular cyst J:91352
ovary hemorrhage J:91352
ovary hypoplasia J:91352
small adrenal glands J:91352
small testis J:91352
testis hypoplasia J:91352
Amhr2tm3(cre)Bhr/Amhr2+
Wnt4tm1Amc/Wnt4tm1.1Bhr
involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J
normal reproductive system phenotype J:171430
Amhr2tm3(cre)Bhr/Amhr2+
Fsttm1Zuk/Fsttm2Zuk
involves: 129S/SvEv * C57BL/6J
abnormal ovary morphology J:89081
abnormal ovulation J:89081
decreased circulating testosterone level J:89081
decreased corpora lutea number J:89081
decreased litter size J:89081
female infertility J:89081
normal homeostasis/metabolism phenotype J:89081
impaired fertilization J:89081
impaired ovarian folliculogenesis J:89081
increased circulating follicle stimulating hormone level J:89081
increased circulating luteinizing hormone level J:89081
ovary cysts J:89081
ovary hemorrhage J:89081
reduced female fertility J:89081
normal reproductive system phenotype J:89081
Amhr2tm3(cre)Bhr/Amhr2+
Smad3tm1Par/Smad3tm1Zuk
involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6
normal reproductive system phenotype J:142827
Amhr2tm3(cre)Bhr/Amhr2+
Smad2tm1Cxd/Smad2tm1.1Mwst
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6
normal reproductive system phenotype J:142827
Amhr2tm3(cre)Bhr/Amhr2+
Smad2tm1Cxd/Smad2tm1.1Mwst
Smad3tm1Par/Smad3tm1Zuk
involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6
abnormal cumulus expansion J:142827
abnormal ovarian follicle morphology J:142827
abnormal secondary ovarian follicle morphology J:142827
decreased litter size J:142827
decreased oocyte number J:142827
increased circulating follicle stimulating hormone level J:142827
increased circulating luteinizing hormone level J:142827
reduced female fertility J:142827
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6
increased granulosa cell tumor incidence J:186144
increased testis tumor incidence J:186144
male infertility J:186144
seminiferous tubule degeneration J:186144
testicular atrophy J:186144
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ
abnormal pulmonary circulation J:142150
anemia J:142150
decreased hematocrit J:142150
extramedullary hematopoiesis J:142150
increased granulosa cell tumor incidence J:149060
increased metastatic potential J:142150, J:149060
increased ovary tumor incidence J:142150
increased testis tumor incidence J:149060
premature death J:142150
seminiferous tubule degeneration J:149060
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6
increased granulosa cell tumor incidence J:186144
increased testis tumor incidence J:186144
Amhr2tm3(cre)Bhr/Amhr2+
Inhbatm1Zuk/Inhbatm3Zuk
involves: 129S7/SvEvBrd * C57BL/6J
decreased litter size J:125354
increased corpora lutea number J:125354
polyovular ovarian follicle J:125354
reduced female fertility J:125354
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ
abnormal Mullerian duct morphology J:171430
abnormal sex determination J:171430
failure of Mullerian duct regression J:171430
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2.1Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6
early reproductive senescence J:128934
hemoperitoneum J:128934
increased ovarian carcinoma incidence J:128934
increased ovary tumor incidence J:128934
increased testis tumor incidence J:128934
male infertility J:128934
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2.1Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J
increased granulosa cell tumor incidence J:157310
premature death J:157310
suppressed circulating follicle stimulating hormone level J:157310
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Huy
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J
increased granulosa cell tumor incidence J:157310
premature death J:157310
suppressed circulating follicle stimulating hormone level J:157310
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6
early reproductive senescence J:128934
hemoperitoneum J:128934
increased ovarian carcinoma incidence J:128934
increased ovary tumor incidence J:128934
increased testis tumor incidence J:128934
male infertility J:128934
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J
increased granulosa cell tumor incidence J:157310
premature death J:157310
suppressed circulating follicle stimulating hormone level J:157310
Amhr2tm3(cre)Bhr/Amhr2+
Smad1tm2Rob/Smad1tm2Rob
Smad5tm1Huy/Smad5tm1Zuk
Smad9tm1Jfm/Smad9tm1Jfm
involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6
early reproductive senescence J:128934
hemoperitoneum J:128934
increased ovarian carcinoma incidence J:128934
increased ovary tumor incidence J:128934
Amhr2tm3(cre)Bhr/Amhr2+
Ptentm1Hwu/Ptentm1Hwu
involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6
abnormal endometrium morphology J:170203
abnormal maternal decidual layer morphology J:170203
abnormal myometrium morphology J:170203
abnormal placenta labyrinth morphology J:170203
abnormal placenta vasculature J:170203
abnormal trophoblast layer morphology J:170203
decreased litter size J:170203
decreased uterine NK cell number J:170203
endometrium fibrosis J:170203
endometrium hyperplasia J:170203
reduced female fertility J:170203
normal reproductive system phenotype J:187754
uterus hyperplasia J:170203
Amhr2tm3(cre)Bhr/Amhr2+
Bmpr1atm1Bhr/Bmpr1atm2.1Bhr
involves: 129S7/SvEvBrd * C57BL/6
male pseudohermaphroditism J:89999
secondary sex reversal J:89999
Amhr2tm3(cre)Bhr/Amhr2+
Stk11tm1Rdp/Stk11tm1Rdp
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6
abnormal seminiferous tubule epithelium morphology J:187754
abnormal seminiferous tubule morphology J:187754
abnormal Sertoli cell morphology J:187754
abnormal spermatogenesis J:187754
abnormal testis morphology J:187754
decreased male germ cell number J:187754
decreased testis weight J:187754
normal neoplasm J:187754
small testis J:187754
Amhr2tm3(cre)Bhr/Amhr2+
Artm1Chc/Y
involves: 129S/SvEv * C57BL/6
abnormal meiosis J:118270
abnormal seminiferous tubule morphology J:118270
arrest of male meiosis J:118270
arrest of spermatogenesis J:118270
azoospermia J:118270
decreased circulating testosterone level J:118270
male infertility J:118270
small seminiferous tubules J:118270
small testis J:118270
Amhr2tm3(cre)Bhr/Amhr2+
Tsc1tm1Djk/Tsc1tm1Djk
involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6
abnormal seminiferous tubule epithelium morphology J:187754
abnormal seminiferous tubule morphology J:187754
abnormal Sertoli cell morphology J:187754
abnormal spermatogenesis J:187754
abnormal testis morphology J:187754
decreased male germ cell number J:187754
decreased testis weight J:187754
normal neoplasm J:187754
small testis J:187754
Amhr2tm3(cre)Bhr/Amhr2+
Trp53tm2Tyj/Trp53+
involves: 129S4/SvJae * 129S7/SvEvBrd
normal neoplasm J:222579
Amhr2tm3(cre)Bhr/Amhr2+
Nr2f2tm2.1Tsa/Nr2f2tm2.1Tsa
involves: 129S7/SvEvBrd
abnormal maternal decidual layer morphology J:120852
abnormal miscarriage rate J:120852
abnormal myometrium morphology J:120852
abnormal placenta development J:120852
abnormal placental labyrinth vasculature morphology J:120852
abnormal spongiotrophoblast cell morphology J:120852
abnormal uterine environment J:120852
absent placental labyrinth J:120852
edema J:120852
embryonic lethality, incomplete penetrance J:120852
hemorrhage J:120852
impaired embryo implantation J:120852
increased trophoblast giant cell number J:120852
reduced female fertility J:120852
short uterine horn J:120852
Amhr2tm3(cre)Bhr/Amhr2+
Dicer1tm1Bdh/Dicer1tm1Bdh
involves: 129
abnormal oviduct morphology J:142113
abnormal oviduct transport J:142113
abnormal pregnancy J:142113
abnormal superovulation J:142113
abnormal uterus morphology J:142113
decreased circulating progesterone level J:142113
decreased endometrial gland number J:142113
decreased ovary weight J:142113
decreased ovulation rate J:142113
decreased uterus weight J:142113
failure of embryo implantation J:142113
female infertility J:142113
normal homeostasis/metabolism phenotype J:142113
normal reproductive system phenotype J:142113
short oviduct J:142113
short uterine horn J:142113
small uterus J:142113
thin myometrium J:142113
Amhr2tm3(cre)Bhr/Amhr2+
Smad4tm1Rob/Smad4tm1.1Rob
involves: 129S/SvEv * C57BL/6J
abnormal cumulus expansion J:108954
abnormal granulosa cell morphology J:108954
abnormal ovarian follicle morphology J:108954
abnormal ovarian folliculogenesis J:108954
abnormal secondary ovarian follicle morphology J:108954
absent cumulus expansion J:108954
decreased litter size J:108954
decreased mature ovarian follicle number J:108954
decreased oocyte number J:108954
decreased ovulation rate J:108954
increased circulating progesterone level J:108954
infertility J:108954
Amhr2tm3(cre)Bhr/Amhr2+
Tsc2tm1.1Mjg/Tsc2tm1.1Mjg
involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6
abnormal seminiferous tubule epithelium morphology J:187754
abnormal seminiferous tubule morphology J:187754
abnormal Sertoli cell morphology J:187754
abnormal spermatogenesis J:187754
abnormal testis morphology J:187754
decreased male germ cell number J:187754
decreased testis weight J:187754
normal neoplasm J:187754
small testis J:187754
Amhr2tm3(cre)Bhr/Amhr2+
Ptprvtm1Kry/Ptprvtm1Kry
involves: 129S/SvEv
normal reproductive system phenotype J:170888
Amhr2tm3(cre)Bhr/Amhr2+
Wnt4tm1.1Boer/Wnt4tm1.2Boer
involves: 129S1/Sv * 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ
abnormal kidney development J:162337
abnormal ovary development J:162337
decreased litter size J:162337
decreased mature ovarian follicle number J:162337
decreased ovary weight J:162337
decreased renal glomerulus number J:162337
disheveled coat J:162337
postnatal growth retardation J:162337
premature death J:162337
Ctnnb1tm1Mmt/Ctnnb1+
Krastm4Tyj/Kras+
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6
increased granulosa cell tumor incidence J:186144
increased testis tumor incidence J:186144
seminiferous tubule degeneration J:186144
Dicer1tm1Tara/Dicer1tm1Tara
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S7/SvEvBrd
normal neoplasm J:222579
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
abnormal oviduct morphology J:182161
ascites J:182161
increased carcinoma incidence J:182161
increased metastatic potential J:182161
increased ovarian carcinoma incidence J:182161
premature death J:182161
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
ascites J:222579
increased carcinoma incidence J:222579
increased metastatic potential J:222579
increased ovarian carcinoma incidence J:222579
premature death J:222579
Dicer1tm1Tara/Dicer1tm1Tara
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
normal neoplasm J:222579
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Foxo3tm1Rdp/Foxo3tm1.1Rdp
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S6/SvEvTac * 129S7/SvEvBrd
abnormal circulating hormone level J:232961
abnormal ovarian follicle morphology J:232961
decreased circulating luteinizing hormone level J:232961
increased circulating estradiol level J:232961
increased granulosa cell tumor incidence J:232961
ovary cysts J:232961
suppressed circulating follicle stimulating hormone level J:232961
Inhbatm1Zuk/Inhbatm3Zuk
Inhbbtm1Jae/Inhbbtm1Jae
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J
abnormal ovarian follicle morphology J:125354
abnormal secondary ovarian follicle morphology J:125354
absent oocytes J:125354
female infertility J:125354
increased corpora lutea number J:125354
increased follicle stimulating hormone level J:125354
increased ovary weight J:125354
ovary cysts J:125354
Kmt2btm1Afst/Kmt2btm1.1Afst
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6
abnormal DNA methylation J:166778
abnormal ovarian follicle number J:166778
increased circulating follicle stimulating hormone level J:166778
reduced female fertility J:166778
Ptentm1Hwu/Ptentm1Hwu
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S4/SvJae * 129S7/SvEvBrd
abnormal pregnancy J:142150
decreased litter size J:142150
increased granulosa cell tumor incidence J:142150, J:222579
increased metastatic potential J:142150
normal reproductive system phenotype J:142150
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd
ascites J:222579
increased granulosa cell tumor incidence J:222579
increased metastatic potential J:222579
increased ovarian carcinoma incidence J:222579
premature death J:222579
Tspotm1.1Wbd/Tspotm1.1Wbd
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6
normal reproductive system phenotype J:207708

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
06/12/2018
MGI 6.12
The Jackson Laboratory